Literature DB >> 25619247

The myosin mesa and a possible unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy.

James A Spudich1.   

Abstract

No matter how many times one explores the structure of the myosin molecule, there is always something new to discover. Here, I describe the myosin mesa, a structural feature of the motor domain that has the characteristics of a binding domain for another protein, possibly myosin-binding protein C (MyBP-C). Interestingly, many well-known hypertrophic cardiomyopathy (HCM) mutations lie along this surface and may affect the putative interactions proposed here. A potential unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy is discussed here. It involves increased power output of the cardiac muscle as a result of HCM mutations causing the release of inhibition by myosin binding protein C.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25619247      PMCID: PMC4349527          DOI: 10.1042/BST20140324

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  43 in total

Review 1.  The myosin swinging cross-bridge model.

Authors:  J A Spudich
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

2.  A FRET-based sensor reveals large ATP hydrolysis-induced conformational changes and three distinct states of the molecular motor myosin.

Authors:  W M Shih; Z Gryczynski; J R Lakowicz; J A Spudich
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

3.  Cytoskeletal elements of chick embryo fibroblasts revealed by detergent extraction.

Authors:  S Brown; W Levinson; J A Spudich
Journal:  J Supramol Struct       Date:  1976

4.  Binding of myosin binding protein-C to myosin subfragment S2 affects contractility independent of a tether mechanism.

Authors:  Samantha P Harris; Elena Rostkova; Mathias Gautel; Richard L Moss
Journal:  Circ Res       Date:  2004-10-07       Impact factor: 17.367

5.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

6.  Fluorescent actin filaments move on myosin fixed to a glass surface.

Authors:  S J Kron; J A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Movement of myosin-coated beads on oriented filaments reconstituted from purified actin.

Authors:  J A Spudich; S J Kron; M P Sheetz
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

Review 8.  Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium.

Authors:  Richard L Moss; Daniel P Fitzsimons; J Carter Ralphe
Journal:  Circ Res       Date:  2015-01-02       Impact factor: 17.367

9.  Myosin subfragment-1 is sufficient to move actin filaments in vitro.

Authors:  Y Y Toyoshima; S J Kron; E M McNally; K R Niebling; C Toyoshima; J A Spudich
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

10.  Disruption of the Dictyostelium myosin heavy chain gene by homologous recombination.

Authors:  A De Lozanne; J A Spudich
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

View more
  56 in total

1.  A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.

Authors:  Eric M Green; Hiroko Wakimoto; Robert L Anderson; Marc J Evanchik; Joshua M Gorham; Brooke C Harrison; Marcus Henze; Raja Kawas; Johan D Oslob; Hector M Rodriguez; Yonghong Song; William Wan; Leslie A Leinwand; James A Spudich; Robert S McDowell; J G Seidman; Christine E Seidman
Journal:  Science       Date:  2016-02-05       Impact factor: 47.728

2.  A Cardiomyopathy Mutation in the Myosin Essential Light Chain Alters Actomyosin Structure.

Authors:  Piyali Guhathakurta; Ewa Prochniewicz; Osha Roopnarine; John A Rohde; David D Thomas
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

3.  Super-relaxation helps muscles work more efficiently.

Authors:  Kenneth S Campbell
Journal:  J Physiol       Date:  2017-02-15       Impact factor: 5.182

4.  Myosin filament activation in the heart is tuned to the mechanical task.

Authors:  Massimo Reconditi; Marco Caremani; Francesca Pinzauti; Joseph D Powers; Theyencheri Narayanan; Ger J M Stienen; Marco Linari; Vincenzo Lombardi; Gabriella Piazzesi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

5.  Force-Dependent Recruitment from the Myosin Off State Contributes to Length-Dependent Activation.

Authors:  Kenneth S Campbell; Paul M L Janssen; Stuart G Campbell
Journal:  Biophys J       Date:  2018-07-11       Impact factor: 4.033

6.  Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers.

Authors:  Robert L Anderson; Darshan V Trivedi; Saswata S Sarkar; Marcus Henze; Weikang Ma; Henry Gong; Christopher S Rogers; Joshua M Gorham; Fiona L Wong; Makenna M Morck; Jonathan G Seidman; Kathleen M Ruppel; Thomas C Irving; Roger Cooke; Eric M Green; James A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-13       Impact factor: 11.205

7.  Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation.

Authors:  Julian R Homburger; Eric M Green; Colleen Caleshu; Margaret S Sunitha; Rebecca E Taylor; Kathleen M Ruppel; Raghu Prasad Rao Metpally; Steven D Colan; Michelle Michels; Sharlene M Day; Iacopo Olivotto; Carlos D Bustamante; Frederick E Dewey; Carolyn Y Ho; James A Spudich; Euan A Ashley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

8.  The mesa trail and the interacting heads motif of myosin II.

Authors:  John L Woodhead; Roger Craig
Journal:  Arch Biochem Biophys       Date:  2019-12-13       Impact factor: 4.013

9.  The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.

Authors:  Suman Nag; Darshan V Trivedi; Saswata S Sarkar; Arjun S Adhikari; Margaret S Sunitha; Shirley Sutton; Kathleen M Ruppel; James A Spudich
Journal:  Nat Struct Mol Biol       Date:  2017-05-08       Impact factor: 15.369

10.  Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil.

Authors:  Wanjian Tang; William C Unrath; Rohini Desetty; Christopher M Yengo
Journal:  J Biol Chem       Date:  2019-10-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.